Back to Seven Fleet Capital Management LP

Seven Fleet Capital Management LP

All holdings · as of Dec 31, 2025

85 positions

CompanyClassValueShares% of portfolio
PROTAGONIST THERAPEUTICS INC$698.7K8,0000.5%
Relmada Therapeutics, Inc.$744.3K154,1090.6%
PALISADE BIO, INC.$769.6K327,5000.6%
KalVista Pharmaceuticals Inc$781.9K48,4120.6%
Celcuity Inc.CELCCommon Stock$782.9K7,8490.6%
Praxis Precision Medicines, Inc.$795.8K2,7000.6%
AGIOS PHARMACEUTICALS, INC.$863.9K31,7380.7%
Zura Bio Limited$872.5K166,5000.7%
Silence Therapeutics plcSLNADR$897.4K147,6000.7%
Taysha Gene Therapies, Inc.TSHACommon Stock$919.7K167,2230.7%
LeonaBio, Inc.LONACommon Stock$968.6K127,9510.7%
Krystal Biotech, Inc.$986.2K4,0000.8%
GERON CORP$1.03M777,8800.8%
MADRIGAL PHARMACEUTICALS, INC.$1.08M1,8600.8%
Inhibikase Therapeutics, Inc.$1.09M533,6480.8%
Avalo Therapeutics, Inc.$1.15M63,3430.9%
VAXCYTE, INC.$1.17M25,3650.9%
AMICUS THERAPEUTICS INC$1.17M82,5000.9%
ASCENDIS PHARMA A/S$1.21M5,6700.9%
Nuvalent, Inc.$1.27M12,6011.0%
Dyne Therapeutics, Inc.$1.37M70,1801.0%
BELITE BIO, INCBLTEADR$1.47M9,1611.1%
Terns Pharmaceuticals, Inc.$1.49M36,8941.1%
Pharvaris N.V.$1.54M55,3421.2%
Xencor Inc$1.68M109,5541.3%
Tango Therapeutics, Inc.$1.91M215,1721.4%
Cogent Biosciences, Inc.$1.92M54,0251.5%
Tyra Biosciences, Inc.$2.09M79,5601.6%
Axsome Therapeutics, Inc.$2.37M12,9551.8%
EXELIXIS, INC.$3.01M68,5692.3%
Compass Therapeutics, Inc.$3.05M568,7472.3%
Liquidia CorpLQDACommon Stock$3.15M91,2672.4%
Revolution Medicines, Inc.$5.24M65,8004.0%
SOLENO THERAPEUTICS, INC.$6.02M130,0794.6%
CG Oncology, Inc.$62.91M1,515,15147.8%
← PrevPage 2 of 2Next →